Peter Knudsen
Peter Knudsen joined Patent GC in 2021, bringing a combination of business acumen and patent strategy to his technology and academic clients. Peter’s practice has included developing patent platforms for new drugs, including proteins; new biologics, including nanoparticle formulations for delivery of proteins and nucleic acids; and manufacture of nanoparticles. Read More